White paper

International Reference Pricing (IRP): Foundations, shifts, and what to do next

Understand how IRP shapes pricing in 75+ markets, what’s driving policy shifts, and how to adapt global launch and access strategies.

Key highlights

This white paper explains how IRP is used to set medicine prices across more than 75 markets, why policies are shifting (including new U.S. MFN-style models and moves toward confidential pricing), and what these changes mean for affordability, access, innovation, and global launch strategy.
International reference pricing white paper

Download white paper to learn more

Pardot Form

We’re here to help

Connect with our team today to learn more about how Cencora is helping to shape the future of healthcare.
abstract

Related resources

Article

EU JCA and US MFN collision: The next global pricing and market access risk frontier

Article

The future of managed care: How AI can transform pharmacy operations by 2030
A light-skinned person with long brown hair holding a tablet and stylus smiles at a colleague during a meeting in a conference room.

Article

IRP: The global impact of a single price decision